Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder

Behavioral and Brain Functions

Volumn 8, Issue , 2012, Pages

  Cao, Ai hua ^a   Yu, Lin ^a   Wang, Yu wei ^a   Wang, Jun mei ^a   Yang, Le jin ^a   Lei, Ge fei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Attention deficit hyperactivity disorder; Attentional set shifting; Methylphenidate; Spontaneous hypertensive rat

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; ATTENTIONAL SET SHIFTING; COMPOUND DISCRIMINATION; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; GENETIC MODEL; HABITUATION; LEARNING; LOW DRUG DOSE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; THERAPY EFFECT;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; MALE; METHYLPHENIDATE; MODELS, GENETIC; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REACTION TIME; SPECIES SPECIFICITY;

EID: 84862796190     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-8-10     Document Type: Article

References (45)

1. Lawrence V, Houghton S, Douglas G, Durkin K, Whiting K, Tannock B. Executive function and ADHD: a comparison of children's performance during neuropsychological testing and real-world activities. J Atten Disord 2004, 7:137-149. 10.1177/108705470400700302, 15260171.
2. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2005, 44:377-384. 10.1097/01.chi.0000153228.72591.73, 15782085.
3. Chamberlain SR, Robbins TW, Winder-Rhodes S, Muller U, Sahakian BJ, Blackwell AD, et al. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry 2010, 69:1192-1203.
4. Kado Y, Sanada S, Yanaqihara M, Ogino T, Abiru K, Nakano K, et al. Clinical application of the modified wisconsin card sorting test to children with attention deficit/hyperactivity disorder. No To Hattatsu 2005, 37:380-385.
5. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247. 10.1016/j.biopsych.2005.02.002, 15949994.
6. Kantak KM, Singh T, Kerstetter KA, Dembro KA, Mutebi MM, Harvey RC, et al. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder. Behav Neurosci 2008, 122:340-357.
7. Chess AC, Raymond BE, Gardner-Morse IG, Stefani MR, Green JT. Set shifting in a rodent model of attention-deficit/hyperactivity disorder. Behav Neurosci 2011, 125:372-382.
8. Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 2000, 20:4320-4324.
9. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psych Med 1999, 29:527-538.
10. McLean A, Dowson J, Toone B, Young S, Bazanis E, Robbins TW, et al. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psych Med 2004, 34:681-692.
11. Goldberg MC, Mostofsky SH, Cutting LE, Mahone EM, Astor BC, Denckla MB, et al. Subtle executive impairment in children with autism and children with ADHD. J Autism Dev Disord 2005, 35:279-293. 10.1007/s10803-005-3291-4, 16119469.
12. Pasini A, Paloscia C, Alessandrelli R, Porfirio MC, Curatolo P. Attention and executive functions profile in drug naive ADHD subtypes. Brain Dev 2007, 29:400-408. 10.1016/j.braindev.2006.11.010, 17207595.
13. Toplak ME, Bucciarelli SM, Jain U, Tannock R. Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol 2009, 15:53-72.
14. Grant DA, Berg EA. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a weigl-type card-sorting problem. J Exp Psychol 1948, 38:404-411.
15. Colacicco G, Welzl H, Lipp HP, Wurbel H. Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation. Behav Brain Res 2002, 132:95-102. 10.1016/S0166-4328(01)00391-6, 11853862.
16. Mehta MA, Goodyer IM, Sahakian BJ. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 2004, 45:293-305. 10.1111/j.1469-7610.2004.00221.x, 14982243.
17. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 2000, 20:65.
18. Gray JD, Punsoni M, Tabori NE, Melton JT, Fanslow V, Ward MJ, et al. Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. J Neurosci 2007, 27:7196-7207. 10.1523/JNEUROSCI.0109-07.2007, 17611273.
19. Devilbiss DM, Berridge CW. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry 2008, 64:626-635. 10.1016/j.biopsych.2008.04.037, 2603602, 18585681.
20. Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 2005, 1:2. 10.1186/1744-9081-1-2, 1143775, 15916700.
21. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60:1111-1120. 10.1016/j.biopsych.2006.04.022, 16806100.
22. Zhu N, Weedon J, Dow-Edwards DL. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci 2007, 121:1272-1279.
23. Yang PB, Swann AC, Dafny N. Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats. Behav Brain Funct 2006, 2:3. 10.1186/1744-9081-2-3, 1360669, 16417623.
24. Klein-Schwartz W. Pediatric methylphenidate exposures: 7-year experience of poison centers in the United States. Clin Pediatr (Phila) 2003, 42:159-164.
25. Konrad K, Gunther T, Hanisch C, Hanisch C, Herpertz-Dahlmann B. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2004, 43:191-198. 10.1097/00004583-200402000-00015, 14726726.
26. Rhodes SM, Coghill DR, Matthews K. Acute neuropsychological effects of methylphenidate in stimulant drug-naive boys with ADHD II-broader executive and non-executive domains. J Child Psychol Psychiatry 2006, 47:1184-1194. 10.1111/j.1469-7610.2006.01633.x, 17076758.
27. Li QQ, Guo LT, Huang XZ, Yang C, Guo TY, Sun JH. Analysis on neuropsychological characteristics of subtypes of attention deficit hyperactivity disorder. Zhonghua Er Ke Za Zhi 2008, 46:64-68.
28. Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 2007, 62:954-962. 10.1016/j.biopsych.2006.12.030, 17543895.
29. Wood ER, Dudchenko PA, Eichenbaum H. The global record of memory in hippocampal neuronal activity. Nature 1999, 397:613-616. 10.1038/17605, 10050854.
30. Ragozzino ME, Detrick S, Kesner RP. Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. Journal of Neuroscience 1999, 19:4585-4594.
31. Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C, Tse MT. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 2006, 31:297-309. 10.1038/sj.npp.1300825, 16012531.
32. Floresco SB, Ghods-Sharifi S, Vexelman C, Magyar O. Dissociable roles for the nucleus accumbens core and shell in regulating set shifting. J Neurosci 2006, 26:2449-2457. 10.1523/JNEUROSCI.4431-05.2006, 16510723.
33. Floresco SB, Zhang Y, Enomoto T. Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav Brain Res 2009, 204:396-409. 10.1016/j.bbr.2008.12.001, 19110006.
34. Haluk DM, Floresco SB. Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 2009, 34:2041-2052. 10.1038/npp.2009.21, 19262467.
35. Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging?. Cogn Affect Behav Neurosci 2010, 10:243-251. 10.3758/CABN.10.2.243, 2877277, 20498348.
36. Sagvolden T, Johansen EB, Woien G, Walaas SI, Storm-Mathisen J, Bergersen LH, et al. The spontaneously hypertensive rat model of ADHD-the importance of selecting the appropriate reference strain. Neuropharmacology 2009, 57:619-626. 10.1016/j.neuropharm.2009.08.004, 2783904, 19698722.
37. Balint S, Czobor P, Meszaros A, Simon V, Bitter I. Neuropsychological impairments in adult attention deficit hyperactivity disorder: a literature review. Psychiatr Hung 2008, 23:324-335.
38. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995, 58:598-606. 10.1136/jnnp.58.5.598, 1073493, 7745410.
39. Garner JP, Thogerson CM, Wurbel H, Murray JD, Mench JA. Animal neuropsychology: validation of the intra-dimensional extra-dimensional set shifting task for mice. Behav Brain Res 2006, 173:53-61. 10.1016/j.bbr.2006.06.002, 16842867.
40. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998, 94:127-152. 10.1016/S0166-4328(97)00175-7, 9708845.
41. Douglas VI, Barr RG, Desilets J, Sherman E. Do high doses of stimulants impair flexible thinking in attention-deficit hyperactivity disorder?. J Am Acad Child Adolesc Psychiatry 1995, 34:877-885. 10.1097/00004583-199507000-00011, 7649958.
42. Stuss DT, Levine B, Alexander MP, Hong J, Palumbo C, Hamer L, et al. Wisconsin Card Sorting Test performance in patients with focal frontal and posterior brain damage: effects of lesion location and test structure on separable cognitive processes. Neuropsychologia 2000, 38:388-402. 10.1016/S0028-3932(99)00093-7, 10683390.
43. McAlonan K, Brown VJ. Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 2003, 146:97-103. 10.1016/j.bbr.2003.09.019, 14643463.
44. O'Doherty J, Critchley H, Deichmann R, Dolan RJ. Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices. J Neurosci 2003, 23:7931-7939.
45. Lee JS, Kim BN, Kang E, Lee DS, Kim YK, Chung JK, et al. Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment. Hum Brain Mapp 2005, 24:157-164. 10.1002/hbm.20067, 15486990.